These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34668082)

  • 41. Zein-maltodextrin nanocomplex based dissolving microneedle: A promising approach for Paliperidone palmitate delivery.
    Londhe VY; Bhadale RS
    Int J Biol Macromol; 2023 Jul; 244():125418. PubMed ID: 37330092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-acting microneedle formulations.
    Vora LK; Sabri AH; Naser Y; Himawan A; Hutton ARJ; Anjani QK; Volpe-Zanutto F; Mishra D; Li M; Rodgers AM; Paredes AJ; Larrañeta E; Thakur RRS; Donnelly RF
    Adv Drug Deliv Rev; 2023 Oct; 201():115055. PubMed ID: 37597586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
    Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
    Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Permeation of sumatriptan succinate across human skin using multiple types of self-dissolving microneedle arrays fabricated from sodium hyaluronate.
    Wu D; Katsumi H; Quan YS; Kamiyama F; Kusamori K; Sakane T; Yamamoto A
    J Drug Target; 2016 Sep; 24(8):752-8. PubMed ID: 26878569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fabrication of biodegradable composite microneedles based on calcium sulfate and gelatin for transdermal delivery of insulin.
    Yu W; Jiang G; Liu D; Li L; Chen H; Liu Y; Huang Q; Tong Z; Yao J; Kong X
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():725-734. PubMed ID: 27987766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fabrication, characterization and comparison of α-arbutin loaded dissolving and hydrogel forming microneedles.
    Aung NN; Ngawhirunpat T; Rojanarata T; Patrojanasophon P; Pamornpathomkul B; Opanasopit P
    Int J Pharm; 2020 Aug; 586():119508. PubMed ID: 32512227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fabrication of coated polymer microneedles for transdermal drug delivery.
    Chen Y; Chen BZ; Wang QL; Jin X; Guo XD
    J Control Release; 2017 Nov; 265():14-21. PubMed ID: 28344014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.
    Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative efficacy evaluation of different penetration enhancement strategies for dermal delivery of poorly soluble drugs - A case with sertaconazole nitrate.
    Bubić Pajić N; Vucen S; Ilić T; O'Mahony C; Dobričić V; Savić S
    Eur J Pharm Sci; 2021 Sep; 164():105895. PubMed ID: 34087357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biphasic burst and sustained transdermal delivery in vivo using an AI-optimized 3D-printed MN patch.
    Bagde A; Dev S; Madhavi K Sriram L; Spencer SD; Kalvala A; Nathani A; Salau O; Mosley-Kellum K; Dalvaigari H; Rajaraman S; Kundu A; Singh M
    Int J Pharm; 2023 Apr; 636():122647. PubMed ID: 36754185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Industrializable approach for preparing hydrogel microneedles and their application in melanoma treatment.
    Xing M; Yang G; Liu H; Zhou Z; Zhang S; Gao Y
    Int J Pharm; 2024 Mar; 653():123883. PubMed ID: 38341048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microneedles with Controlled Bubble Sizes and Drug Distributions for Efficient Transdermal Drug Delivery.
    Wang QL; Zhu DD; Liu XB; Chen BZ; Guo XD
    Sci Rep; 2016 Dec; 6():38755. PubMed ID: 27929104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incorporating surfactants into PCL microneedles for sustained release of a hydrophilic model drug.
    Bader N; Abu Ammar A
    Int J Pharm; 2024 Mar; 652():123826. PubMed ID: 38253267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of polymeric microneedle arrays for transdermal drug delivery.
    Demir YK; Akan Z; Kerimoglu O
    PLoS One; 2013; 8(10):e77289. PubMed ID: 24194879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanomaterials-incorporated polymeric microneedles for wound healing applications.
    Duan W; Xu K; Huang S; Gao Y; Guo Y; Shen Q; Wei Q; Zheng W; Hu Q; Shen JW
    Int J Pharm; 2024 Jun; 659():124247. PubMed ID: 38782153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microneedle array systems for long-acting drug delivery.
    Vora LK; Moffatt K; Tekko IA; Paredes AJ; Volpe-Zanutto F; Mishra D; Peng K; Raj Singh Thakur R; Donnelly RF
    Eur J Pharm Biopharm; 2021 Feb; 159():44-76. PubMed ID: 33359666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study on the fabrication and characterization of tip-loaded dissolving microneedles for transdermal drug delivery.
    Zhuang J; Rao F; Wu D; Huang Y; Xu H; Gao W; Zhang J; Sun J
    Eur J Pharm Biopharm; 2020 Dec; 157():66-73. PubMed ID: 33059004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fabrication of pure-drug microneedles for delivery of montelukast sodium.
    Azizoglu E; Ozer O; Prausnitz MR
    Drug Deliv Transl Res; 2022 Feb; 12(2):444-458. PubMed ID: 34480297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ex vivo evaluation of a microneedle array device for transdermal application.
    Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
    Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.